DAPT -Dual anti-platelet therapy has become a standard in many clinical situations of CAD.There has been significant confusion about ,Indications, best combination, duration of DAPT, withholding of DAPT, conversion to MAPT (mono) etc.The JACC september 2016 issue brings much needed clarity on this issue.
Link to key summary from NEJM journal watch.
http://www.jwatch.org/na42407/2016/09/28/update-dual-antiplatelet-therapy-patients-with-coronary?
Full text guideline
Leave a Reply